Cargando…

Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study

BACKGROUND: The identification of new biomarkers in autosomal-dominant polycystic kidney disease (ADPKD) is crucial to improve and simplify prognostic assessment as a basis for patient selection for targeted therapies. Post hoc analyses of the TEMPO 3:4 study indicated that copeptin could be one of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arjune, Sita, Oehm, Simon, Todorova, Polina, Gansevoort, Ron T, Bakker, Stephan J L, Erger, Florian, Benzing, Thomas, Burst, Volker, Grundmann, Franziska, Antczak, Philipp, Müller, Roman-Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616446/ https://www.ncbi.nlm.nih.gov/pubmed/37915893 http://dx.doi.org/10.1093/ckj/sfad118

Ejemplares similares

Cyst Fraction as a Biomarker in Autosomal Dominant Polycystic Kidney Disease
por: Karner, Larina A., et al.
Publicado: (2022)

Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
por: Fuchs, Alexander, et al.
Publicado: (2022)

Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life
por: Todorova, Polina, et al.
Publicado: (2023)

Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial
por: Cukoski, Sadrija, et al.
Publicado: (2023)

Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?
por: Tasneem, Moomal, et al.
Publicado: (2018)

Management of autosomal-dominant polycystic kidney disease—state-of-the-art
por: Müller, Roman-Ulrich, et al.
Publicado: (2018)

Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
por: Bais, Thomas, et al.
Publicado: (2022)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

A Low-Cost Sequencing Platform for Rapid Genotyping in ADPKD and its Impact on Clinical Care
por: Lindemann, Christoph Heinrich, et al.
Publicado: (2022)

Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects
por: Strubl, Sebastian, et al.
Publicado: (2021)

Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients
por: Heida, Judith E., et al.
Publicado: (2021)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Thiazide diuretics and the rate of disease progression in autosomal dominant polycystic kidney disease: an observational study
por: Kramers, Bart J, et al.
Publicado: (2020)

Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
por: van Luijk, Franka, et al.
Publicado: (2022)

The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort study
por: Knol, Martine G E, et al.
Publicado: (2021)

Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease
por: Blijdorp, Charles J, et al.
Publicado: (2020)

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease
por: Grantham, Jared J., et al.
Publicado: (2017)

Preoperative Short‐Term Restriction of Sulfur‐Containing Amino Acid Intake for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Double‐Blind, Translational Trial
por: Osterholt, Thomas, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

The impact of pre-transplantation nephrectomy on quality of life in patients with autosomal dominant polycystic kidney disease
por: Geertsema, Paul, et al.
Publicado: (2023)

Introduction of laparoscopic nephrectomy for autosomal dominant polycystic kidney disease as the standard procedure
por: Thomas, M. N., et al.
Publicado: (2023)

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
por: Messchendorp, A. Lianne, et al.
Publicado: (2017)

The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients
por: Casteleijn, Niek F., et al.
Publicado: (2023)

Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial
por: Irazabal, Maria V., et al.
Publicado: (2016)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Nephrotic syndrome and autosomal dominant polycystic kidney disease
por: Visciano, Bianca, et al.
Publicado: (2012)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease: updated perspectives
por: Rastogi, Anjay, et al.
Publicado: (2019)

Educational Case: Autosomal Dominant Polycystic Kidney Disease
por: Frazier, Ryan L., et al.
Publicado: (2020)

Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022)

Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
por: Casteleijn, Niek F., et al.
Publicado: (2016)

Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review
por: Natale, Patrizia, et al.
Publicado: (2021)

T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease
por: van Gastel, Maatje D. A., et al.
Publicado: (2017)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c5efrs75c2noir7i7r0f5rvlo5